FOXO TECHNOLOGIES INC. Net Income (Loss) Attributable to Noncontrolling Interest
FOXO TECHNOLOGIES INC. (FOXO) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$3.19 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$3.19K.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$3.21K.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$4.68K.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$3.42K.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$16.74K.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$14.57K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.19K 10-Q · filed 2026-08-14 | -$6.41K 10-Q · filed 2026-08-14 | -$11.09K derived: sum of 3 quarters · filed 2026-08-14 | -$14.51K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$3.21K 10-Q · filed 2026-08-14 | -$7.89K derived: sum of 2 quarters · filed 2026-08-14 | -$11.32K derived: sum of 3 quarters · filed 2026-08-14 | -$15.60K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$4.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$8.11K derived: sum of 2 quarters · filed 2026-04-15 | -$12.39K derived: sum of 3 quarters · filed 2026-08-14 | -$16.74K 10-K · filed 2026-04-15 | |||
| 2025-09-30 | -$3.42K 10-Q · filed 2025-11-10 | -$7.71K derived: sum of 2 quarters · filed 2026-08-14 | -$12.06K 10-Q · filed 2025-11-10 | -$18.17K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$4.29K 10-Q · filed 2026-08-14 | -$8.63K 10-Q · filed 2026-08-14 | -$14.74K derived: sum of 3 quarters · filed 2026-08-14 | -$21.87K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$4.35K 10-Q · filed 2026-08-14 | -$10.46K derived: sum of 2 quarters · filed 2026-08-14 | -$17.59K derived: sum of 3 quarters · filed 2026-08-14 | -$54.96K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2024-12-31 | -$6.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$13.24K derived: sum of 2 quarters · filed 2026-04-15 | -$50.61K derived: sum of 3 quarters · filed 2026-04-15 | -$14.57K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$7.13K 10-Q · filed 2025-11-10 | -$7.00K 10-Q · filed 2024-11-19 | -$44.50K derived: sum of 2 quarters · filed 2025-11-10 | -$8.46K 10-Q · filed 2025-11-10 | -$8.00K 10-Q · filed 2024-11-19 | ||
| 2024-06-30 | -$37.37K 10-Q · filed 2025-11-10 | -$1.00K 10-Q · filed 2024-08-19 | -$1.33K 10-Q · filed 2025-08-19 | -$1.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |